Statement on vaccine research developments

Discover the most important information for you when you have been recently diagnosed. Your journey to feeling better is just beginning and we’re here every step of the way to help.

About research

Take part in research

For researchers

Donate

Fundraise

Volunteer

Partner with us

Corporate partnerships

Your donations make a real difference

Together, we can create a future where no life is limited by coeliac disease. Thank you for being there for everyone who needs to live gluten free.

Donate

Healthcare Professionals

Schools

Commercial partners

At Coeliac UK we are dedicated to helping businesses provide safe and delicious gluten free options.

Commercial partner support

News

Statement on vaccine research developments

March 21, 2018

We are aware of the reports from Australia which suggest that a vaccine for coeliac disease may be available within two years.

We are aware of the reports from Australia which suggest that a vaccine for coeliac disease may be available within two years. In fact the proposed vaccine is just entering phase two of a three phase clinical trial programme to assess its effectiveness in people with coeliac disease.

Development of new therapeutics for coeliac disease and the essential clinical trials are a complex process. It is difficult to determine the exact time but usually completion of the trial programme takes many years from this point.

The vaccine is based on earlier research funded by Coeliac UK carried out by Dr Bob Anderson which helped him to identify the most toxic fragments of gluten.

ImmusanT has further information about the vaccine programme on its website.

Back to all news